Overview
Xianan Li practices practicing medicine in Changsha, China.
Their clinical expertise encompasses Adult Soft Tissue Sarcoma, Alveolar Soft Part Sarcoma, Osteosarcoma, and Melanoma.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 1 clinical trial.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Xianan Li
Is Xianan Li a top-rated expert for Adult Soft Tissue Sarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Xianan Li is classified as an Experienced expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xianan Li participate in research or clinical trials?
Yes. Xianan Li has published 15 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Xianan Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult Soft Tissue Sarcoma
- Alveolar Soft Part Sarcoma
- Bone TumorLi isExperienced. Learn about Bone Tumor.
- MelanomaLi isExperienced. Learn about Melanoma.
- OsteosarcomaLi isExperienced. Learn about Osteosarcoma.